Sartorius Competitors
Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
---|---|---|---|---|---|---|---|---|
AZN | AstraZeneca PLC | Outperform |
17
|
£121.90 | £134.03 | 39.05% | 16 | £188.97B |
TMO | Thermo Fisher Scientific | Outperform |
10
|
$567.98 | $627.47 | 9.16% | 1 | $216.81B |
ROG | Roche Holding | Hold |
16
|
CHF231.00 | CHF277.53 | 14.72% | 9 | CHF186.49B |
DHR | Danaher | Outperform |
10
|
$256.80 | $272.68 | 6.09% | 4 | $190.21B |
MRK | Merck KGaA | Outperform |
18
|
166.50€ | 184.81€ | 12.91% | 4 | 72.39€B |
PH | Parker-Hannifin Corp | Outperform |
10
|
$531.52 | $597.90 | 16.65% | 7 | $68.32B |
BDX | Becton Dickinson and Co | Outperform |
9
|
$231.97 | $278.69 | 19.63% | 8 | $67.04B |
A | Agilent Technologies | Outperform |
10
|
$130.41 | $141.12 | 8.12% | 10 | $38.03B |
BIIB | Biogen | Outperform |
10
|
$224.94 | $284.72 | 29.81% | 13 | $32.75B |
BAYN | Bayer | Hold |
5
|
28.24€ | 36.64€ | 8.00% | 4 | 27.74€B |
MTD | Mettler-Toledo International | Hold |
13
|
$1.40k | $1.32k | -5.28% | 0 | $29.99B |
STE | STERIS | Outperform |
13
|
$222.88 | $243.50 | 9.70% | 4 | $22.04B |
ENTG | Entegris | Outperform |
18
|
$126.35 | $145.34 | 18.36% | 11 | $19.05B |
RGEN | Repligen | Outperform |
16
|
$149.09 | $187.18 | 37.50% | 12 | $9.21B |
GETI B | Getinge AB | Outperform |
18
|
kr187.00 | kr226.10 | 20.86% | 3 | kr63.33B |
3355 | Kuriyama Holdings | Outperform |
17
|
¥1.22k | ¥0.00 | 7.41% | 0 | ¥18.46B |